Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 2995-3002, November 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rassiga-Pidot, A. L.
Right arrow Articles by McIntyre, O. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rassiga-Pidot, A. L.
Right arrow Articles by McIntyre, O. R.

In Vitro Leukocyte Interferon Production in Patients with Hodgkin's Disease1

Anne L. Rassiga-Pidot2 and O. Ross McIntyre3

Hematology Research Laboratory, Department of Medicine, Dartmouth-Hitchcock Medical Center, Hanover, New Hampshire 03755

Interferon production resulting from Newcastle disease virus stimulation of cultured leukocytes was measured in cells derived from 21 consecutive, untreated, newly diagnosed patients with Hodgkin's disease and in a group of control subjects. In addition, skin tests and phytohemagglutinin-induced lymphocyte blastogenesis were assessed. It was found that interferon production was normal in cells from Stage I, II, and III patients but was impaired in Stage IV patients. The interferon titer produced by the cultured leukocytes was found to be related to the absolute number of lymphocytes as well as glass-adherent cells in the cultures. Cultures prepared from the Hodgkin's patients had a decreased mean mononuclear cell number, but this alone did not account for the impaired responses observed in Stage IV patients. There was no correlation between the phytohemagglutinin response as measured by tritiated thymidine uptake and the interferon produced in response to virus. Likewise, no correlation was found between lymphocyte interferon production and the presence of anergy. Impaired interferon production was observed to return to normal in those patients achieving remission.

1 Presented in part at the Annual Meeting of the American Federation for Clinical Research, May 2, 1971 (20). Supported by NIH Postdoctoral Fellowship FO3-CA42,989 and National Cancer Institute Grant CA04326.

2 Instructor in Medicine, Dartmouth-Hitchcock Medical Center, Hanover, N. H. Currently Assistant Chief, Hematology Section, Veterans Administration Hospital, and Assistant Professor of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.

3 Associate Professor of Medicine, Dartmouth-Hitchcock Medical Center, Hanover, N. H.

Received 6/28/74. Accepted 8/ 7/74.




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. Shehata, J. D. Schwarzmeier, S. T. Nguyen, M. Hilgarth, R. Berger, R. Hubmann, S. Kickmaier, and T. Decker
Reconstitution of Endogenous Interferon {{alpha}} by Recombinant Interferon in Hairy Cell Leukemia
Cancer Res., October 1, 2000; 60(19): 5420 - 5426.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.